Jarushka Naidoo

Jarushka Naidoo is an expert in pulmonary immune-related adverse events, having defined the incidence, clinical features, and management of checkpoint inhibitor-associated pneumonitis. She led large analyses characterizing pneumonitis risk across checkpoint inhibitor classes. Her work established multidisciplinary management protocols for severe pulmonary irAEs and contributed to steroid dosing guidelines.